Twitter

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in NSCLC

Condition:   Non Small Cell Lung Cancer
Interventions:   Drug: AMG 386 Dose 1;   Drug: AMG 386 Dose 2
Sponsors:   Amgen;   Amgen
Recruiting – verified August 2012

Read the original post: Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in NSCLC




Comments are closed.